Search Within

Shanu Modi

  1. "Graduate Medical Education"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
  3. Research Letter (1)
Groups
  1. Breast Medicine Service (6)
  2. Department of Medicine (6)
  3. Graduate Medical Education (6)
  4. Solid Tumor Oncology Division (6)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  6. GME, Medicine (5)

More Groups

People
  1. Pedram Razavi (5)
  2. Sarat Chandarlapaty (5)
  3. Anton Safonov (4)
  4. Emanuela Ferraro (3)
  5. Joshua Drago (3)
  6. Komal Jhaveri (3)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2022 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Advances in Radiation Oncology (1)
  3. Cancer Research (1)
  4. npj Breast Cancer (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Nature Publishing Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Local therapy for isolated central nervous system progression among patients receiving antibody-drug conjugate therapy
    Research Letter

    Lebow, E. S.; Eichholz, J.; Zhang, Z.; Toumbacaris, N.; Imber, B.; Chen, L.; LaPlant, Q.; Yamada, J.; Pike, L. R. G.; Modi, S.; more...
    Advances in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
    Journal Article

    Mai, N.; dos Anjos, C. H.; Razavi, P.; Safonov, A.; Patil, S.; Chen, Y.; Drago, J. Z.; Modi, S.; Bromberg, J. F.; Dang, C. T.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Meeting Abstract

    Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer
    Meeting Abstract

    Ferraro, E.; Moiso, E.; Safonov, A.; Cabel, L.; Loudon, L.; Dang, C. T.; Shen, S.; Jhaveri, K. L.; Robson, M. E.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Predicting CDK4/6 inhibitors outcomes in pts with HR+/HER2-metastatic breast cancer: A machine learning approach
    Meeting Abstract

    Moiso, E.; Ferraro, E.; Cabel, L.; Safonov, A.; Ahmed, M.; An, J. A. R.; Jhaveri, K. L.; Norton, L.; Robson, M. E.; Modi, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Meeting Abstract

    Liu, B.; Drago, J. Z.; Rao, Y.; Pereira, P. R.; Safonov, A.; Marra, A.; Ahmed, M. S.; Modi, S.; Reis, J. S.; Montemurro, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save